Patents
Patents for C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
09/2010
09/14/2010US7795457 antitumor agents; anticancer agents; structurally related to the leptomycin family; Leptolstatin
09/14/2010CA2466292C Method for producing alkyl ketene dimers
09/07/2010US7790900 such as 1-amino-2-phenylpropane by reacting unsaturated nitroolefin with organosilicon compounds such as poly(methylhydrosiloxane) and phenylsilane, in presence of asymmetric copper complex having phosphine ligand
09/01/2010EP1555261B1 Valerolactone compounds and perfume composition
08/2010
08/31/2010US7786316 Metalloprotein inhibitors
08/26/2010US20100216970 Methods, compositions, and apparatuses for forming macrocyclic compounds
08/19/2010US20100210466 4-phenyl-pyrane-3,5-diones,4-phenyl-thiopyrane-3,6-diones and cyclohexanetriones as novel herbicides
08/12/2010US20100202971 Compound having tumor-resident property
08/10/2010US7771695 Diels-Alder adduct of polyacene with dienophile; semiconductors, field effect transistors
07/2010
07/27/2010US7763657 such as N-{-4-[3-(4-t-butylbenzyl)ureidomethyl]-2-vinylphenyl}methanesulfonamide, used as analgesics, and for treating psoriasis, pruritus, asthma, chronic obstructive pulmonary disease, urinary incontinence, inflammatory bowel disease, tinnitus and ischemia
07/15/2010US20100179191 Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
06/2010
06/15/2010US7737287 Anomeric derivatives of monosaccharides
06/10/2010US20100144045 Chiral selectors for separating enantiomers of a compound
06/03/2010US20100136135 Method of Selecting Phosphate Binder and its Uses Thereof
06/01/2010US7728156 Method of performing sugar dehydration and catalyst treatment
05/2010
05/27/2010US20100127211 Five-ring liquid crystal compound having cf20 bonding group, liquid crystal composition, and liquid crystal display device
05/20/2010US20100125144 Hydrogenation of esters with ru/tetradentate ligands complexes
05/20/2010US20100125102 Estrogenic-active compounds and application thereof
05/18/2010US7718814 6-(2,4-dinitrophenylazo)-2,5,7,8-tetramethyltridecyl))-1,2,3,4-tetrahydroquinoline; to treat cell proliferative diseases
05/06/2010US20100113763 Method for preparation of organofluoro compounds in alcohol solvents
05/06/2010US20100112482 Fluorinated monomer of cyclic acetal structure, polymer, resist protective coating composition, resist composition, and patterning process
04/2010
04/27/2010US7705164 Metalloprotein inhibitors
04/22/2010US20100098640 Multidentate Pyrone-Derived Chelators for Medicinal Imaging and Chelation
04/20/2010US7700783 Synthesis of discodermolide and variants thereof
04/15/2010US20100094027 Process for the Preparation of Glycerol Formal
04/15/2010US20100092388 Anthracycline Derivatives
03/2010
03/31/2010CN101683619A Load type nano gold catalyst for preparing lactone by catalyzing air oxidation alpha, omega-diol and preparation method thereof
03/11/2010US20100063141 Deuterated benzylbenzene derivatives and methods of use
03/11/2010US20100063137 Cytotoxin Compound And Method of Isolation
03/11/2010US20100062486 Novel protein and dna encoding the protein
03/09/2010US7674909 Tetrahydroquinoline derivatives and their use as FSH receptor modulators
03/04/2010US20100056528 Sulfonamide derivatives with therapeutic indications
02/2010
02/18/2010US20100041717 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
02/18/2010US20100041665 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
02/18/2010US20100038588 Liquid Crystal Compound Having Lactone Ring, Liquid Crystal Composition, And Liquid Crystal Display Device
02/16/2010US7662790 Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
02/16/2010CA2394270C Process for the co-production of aliphatic diols and cyclic ethers
02/04/2010US20100029913 Biocompatible phase invertible proteinaceous compositions and methods for making and using the same
02/04/2010US20100029579 Antiviral compounds
01/2010
01/28/2010US20100022637 Identification of anti-cancer compounds and compounds for treating huntington's disease and methods of treatment thereof
01/20/2010EP1453821B1 Method for producing alkyl ketene dimers
01/19/2010US7649099 two step processes of producing isosorbide from sorbitol; first step in presence of a solid acid catalyst; second step in presence of a second catalyst selected from sulfuric acid, phosphoric acid, hydrochloric acid and p-toluenesulfonic acid; cost efficiency, environmentally friendly; therapeutic uses
01/07/2010US20100004326 Metabolites of selective androgen receptor modulators and methods of use thereof
01/07/2010US20100000865 Method and reagent for protein analysis
01/05/2010US7642284 Luminacin analogs and uses thereof
12/2009
12/31/2009US20090324854 Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device
12/29/2009US7638641 Tetrahydropyran derivatives
12/24/2009US20090318547 Glucopyranosyl-substituted difluorobenzyl-benzene derivates, medicaments containing such compounds, their use and process for their manufacture
12/24/2009US20090318501 Piperidine derivatives as renin inhibitors
12/17/2009US20090312369 Renin Inhibitors
12/10/2009US20090306411 Process for preparing unsaturated lactones
12/01/2009US7625885 administering Palmerolides, macrocyclic polyketides bearing carbamate and a vinyl amide or aldehyde functionality; extracts from the tunicate Synoicum adareanum, used for treatment of melanoma, colon and renal cancer; anticarcinogenic agents
11/2009
11/18/2009EP2119792A1 Novel macrolide compound
11/17/2009US7618996 Diaryl ether derivatives and uses thereof
11/12/2009WO2009105755A3 Macrocyclic prodrug compounds useful as therapeutics
11/10/2009US7615652 Two-stage dehydration of sugars
11/05/2009US20090275651 Alcanoic Acid Amides Substituted by Saturated O-Heterocycles
10/2009
10/22/2009US20090263336 Novel pyran derivatives and their preparation
10/15/2009WO2009126852A1 Dianhydrosugar production process
10/01/2009US20090247623 Derivatives of epirubicin, their medicinal application and pharmaceuticaly acceptable forms of drugs
09/2009
09/24/2009WO2005113533A9 Process for preparing unsaturated lactones
09/09/2009CN101528725A Method for producing lactones from diols
09/03/2009WO2009105969A1 Epothilone analogues, their pharmaceutical compositions, their use and their preparations
09/03/2009US20090221824 Enantioselective process
09/01/2009US7582749 capable of switching between the two states in response to at least actinic radiation; thermally reversible
08/2009
08/26/2009EP1747211B1 Process for preparing unsaturated lactones
08/25/2009US7579486 Metalloprotein inhibitors
08/25/2009US7579485 Reacting amide in aqueous solution; cyclization
08/20/2009US20090209770 Cis-2, 6-disubstituted tetrahydropyran derivatives and preparation method thereof
08/18/2009US7576225 isolated from the Caenorhabditis elegance related to suppress of aging and stress
08/06/2009US20090198074 Intermediates and methods for the synthesis of halichondrin b analogs
08/04/2009US7569601 Such as (2E)-3-{4-[1-ethyl-2,2-bis(4-hydroxyphenyl)ethenyl]phenyl}-2-propenoic acid; for selective estrogen receptor modulation; menopausal or postmenopausal disorders, vasomotor symptoms, urogenital or vulvar vaginal atrophy, atrophic vaginitis, female sexual dysfunction, breast cancer, osteoporosis
08/04/2009US7569594 antiproliferative agents; cancer
07/2009
07/29/2009EP1461315B1 Catalytic carbonylation of three and four membered heterocycles
07/16/2009US20090182039 Choline Salt Crystal of Azulene Compound
07/02/2009US20090171105 Method for production of hydrochloride 1(10) beta-epoxy-13-dimethylamino-5,7alpha,6,11beta (h)-guaia-3(4)-en-6,12-olide, the lyophilized antitumor preparation 'arglabin'
06/2009
06/25/2009US20090162385 Compositions for and methods of enhancing the immune response to antigens
06/10/2009CN100496718C Catalyst extrudate based on copper oxide and their use for hydrogenating carbonyl compounds
05/2009
05/21/2009US20090130020 Diagnostic agents for positron emission imaging using f-18 radio-labeled amino-alcohols
05/20/2009EP2059265A2 Malodor counteracting compositions and method for their use
05/19/2009CA2387268C Process for the simultaneous production of maleic anhydride and its hydrogenated derivatives
05/12/2009US7531289 4,4-difluoro-5-hydroxy-3-methyl-5-trifluoromethyloxolane-3-yl methacrylate; useful as raw materials for the synthesis of functional materials, pharmaceutical and agricultural chemicals, to produce polymers for the manufacture of radiation-sensitive resist having high transparency
05/05/2009US7528268 Oxidation, in an inert solvent, of a non-aromatic or non-enonic ethylenic bond or of a non-conjugated cyclic ketones into the corresponding epoxides, respectively lactone, using H2O2 and alkaline or alkaline earth salt or complex as catalyst
04/2009
04/22/2009CN100480247C Method for producing 1-hydroperoxy-16-oxabicyclo[10.4.0]hexadecane
04/21/2009US7521568 Enantiopure 4-deoxypentenosides, dihydropyrans and tetrahydropyrans and syntheses thereof
04/16/2009US20090099251 Dietary and pharmaceutical compositions containing tricyclic diterpenes and their derivatives and their uses
04/14/2009CA2256007C Substituted heterocyclic benzocycloalkenes and their use as analgesic
04/02/2009WO2009042708A1 Regeneration anti-inflammatory composition and method for treating a retinal dystrophy using same
03/2009
03/31/2009CA2329353C Method for producing mixtures of 1,4-butanediol, tetrahydrofuran and .gamma.-butyrolactone
03/26/2009US20090082423 Soluble epoxide hydrolase inhibitors
03/24/2009CA2329477C Method for producing 1,4-butanediol
03/19/2009US20090076289 Methods of Making Epothilones
03/19/2009US20090076288 (+)-[2R*[1S*,5S*(S*)]]+[2R*[1S*,5R*(R*)]]- alpha , alpha '-[phenylmethyliminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] is dissolved in diisopropyl ether at reflux temperature and cooled to below about 30 degrees C. to obtain the desired (+)-[2R*[1S*,5S*(S*)]]- isomer
03/19/2009US20090076271 Process for preparing intermediates of HMG-CoA reductase inhibitors
03/19/2009US20090076133 Deuterium-enriched zanamivir
03/11/2009CN100467433C Homogeneous process for the hydrogenation of dicarboxylic acids and/or anhydrides thereof
03/03/2009US7498450 Hydrogenation of dicarboxylic acids to form diols, cyclic ethers and lactones in the presence of an aqueous solution of a ruthenium, rhodium, iron, osmium or palladium compound and a phosphine, preferably tridentate facially capped phosphines (tris-1,1,1-(diarylphosphinomethyl)alkane)
02/2009
02/17/2009US7491833 Valerolactone compounds and perfume composition
02/12/2009US20090043093 Process for Preparing 2-Methoxycarbonylmethyl-6,6-Dimethyl-2-Tetrahydropyran Carboxylic Acid
01/2009
01/29/2009US20090030198 Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 ... 14